Pure Global
Disease/Condition
2 Clinical Trials
1+ Countries

Paronychia,Epidermal Growth Factor Receptor Inhibitor Clinical Trials Database - Free Access to 2 Studies

Access comprehensive clinical trial information for Paronychia,Epidermal Growth Factor Receptor Inhibitor through Pure Global AI's free database. This collection includes 2 clinical trials across multiple phases including N/A.

Research for Paronychia,Epidermal Growth Factor Receptor Inhibitor is being conducted in Taiwan and more. Leading sponsors include Chang Gung Memorial Hospital and Taipei Medical University WanFang Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
2
By Status
Completed
2
Top Countries
Taiwan2
Top Sponsors
Chang Gung Memoria...1
Taipei Medical Uni...1
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Paronychia,Epidermal Growth Factor Receptor Inhibitor Research

Pure Global AI provides free access to 2 clinical trials studying Paronychia,Epidermal Growth Factor Receptor Inhibitor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 1+ countries.

Top research sponsors include Chang Gung Memorial Hospital, Taipei Medical University WanFang Hospital, among others.

Quick Facts
Total Trials2
Countries1+
Sponsors2+
RecruitingN/A